Management, outcomes and predictors of recurrence in chromophobe renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).
Erica Arenovich(Queen Elizabeth II Health Sciences Centre), Lori Wood(Dalhousie University), Simon Tanguay(McGill University Health Centre), Naveen S. Basappa, Rodney H. Breau(University of Ottawa), Aly‐Khan A. Lalani(Juravinski Cancer Centre), Ricardo Rendon(Dalhousie University), Miles P. Mannas, Frédéric Pouliot(Université Laval), Luke T. Lavallée(University of Ottawa), Bimal Bhindi, Georg A. Bjarnason(Sunnybrook Health Science Centre), Patrick O. Richard(Sorbonne Université), Jean‐Baptiste Lattouf(Centre Hospitalier de l’Université de Montréal), Jasmir G. Nayak(CancerCare Manitoba), Antonio Finelli(University Health Network), Rahul Bansal(St. Joseph’s Healthcare Hamilton), Ranjeeta Mallick(University of Ottawa), Daniel Yick Chin Heng(University of Calgary), Andrew Feifer(University of Toronto)
Cited by 0
Related Papers
Prevalence, Risk Factors, and Outcomes of Delirium in Mechanically Ventilated Adults*
|Critical Care Medicine|2014|341
Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling
|Molecular Cancer Research|2018|322
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
|The Journal of Urology|2020|268
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|267